ClinicalTrials.Veeva

Menu

Explanted Lung Tissues With Pulmonary Fibrosis

The University of Chicago logo

The University of Chicago

Status

Enrolling

Conditions

Pulmonary Fibrosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.

Full description

Pulmonary Fibrosis involves scarring of the lung. Gradually, the air sacs of the lungs become replaced by fibrotic tissue. The most current thinking is that the fibrotic process is a reaction to tiny injury to the lung. When the scar forms, the tissue becomes thicker causing a permanent loss of the tissue's ability to carry oxygen into the bloodstream.

We need to obtain lung tissue from patients without pulmonary fibrosis and compare it to lung tissue from patients with pulmonary fibrosis.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients awaiting lung transplant

Exclusion criteria

  • all who will not give consent

Trial contacts and locations

1

Loading...

Central trial contact

Nickolai Dulin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems